Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Brachytherapy is an established treatment for prostate cancer with much to recommend it, but its use is declining as clinicians opt for flashier therapies.
People with prostate cancer currently have several treatment options available to them. But one of the oldest, brachytherapy, is losing popularity with physicians. Without action, the skills needed to perform this effective therapy could be lost.
Some of the most effective modern drugs are complex biological molecules. As their patents expire, drug developers are fashioning copycat versions that could make such therapies cheaper and more broadly available.
